Effect of COVID-19 on diabetes in Black Asian and Minority Ethnic (BAME) patients

Not Applicable

• Conditions: Impact of COVID-19 (SARS-CoV-2 infection) on diabetes in the BAME population; Nutritional, Metabolic, Endocrine; Diabetes mellitus

• Registration Number: ISRCTN15351917
• Lead Sponsor: Darent Valley Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-01
• Study Completion: 2021-11-16
• Last Update Posted: 24 January 2022

Recruitment & Eligibility

• Status: Stopped
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. 18 years and above
2. Identifies as Black, Asian or Minority Ethnic (BAME)
3. Diagnosed COVID-19 with viral PCR nasal swab in hospital or community
4. Diagnosed type 1 or type 2 diabetes mellitus (T1DM or T2DM, according to WHO criteria) prior to or after COVID-19 diagnosis
5. Able to provide informed consent and willing to participate in the study and follow the instructions

Exclusion Criteria

1. From any other demographic not in the BAME group
2. Not confirmed COVID-19 with viral PCR nasal swab in hospital or community
3. Not confirmed T1DM or T2DM according to WHO criteria
4. Unwilling/unable to participate or comply with the protocol

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycated haemoglobin (HbA1c) measured using blood test pre and post COVID-19 infection within 12 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. Body mass index measured using BMI calculator pre and post COVID-19 infection within 12 months<br> 2. Renal function measured using blood test pre and post COVID-19 infection within 12 months<br> 3. Blood pressure measured using calibrated blood pressure machine pre and post COVID-19 infection within 12 months<br> 4. Lipid profile measured using blood test pre and post COVID-19 infection within 12 months<br> 5. Proteinuria measured using urine sample pre and post COVID-19 infection within 12 months<br> 6. Depression, anxiety and eating disorders measured using a psychologist-developed questionnaire (Diabetes and COVID-19 Participant Questionnaire Booklet) post COVID-19 infection within 12 months<br>